Skip to main content

Health condition

CPEO and Kearns-Sayre

Chronic progressive external ophthalmoplegia - slowly failing eyelids and eye movements - sits on a spectrum with Kearns-Sayre syndrome, where heart surveillance becomes lifesaving.

Key points

What matters most, at a glance.

The essentials in plain English - symptoms, when to seek help, who to see and what treatment looks like.

  • CPEO: painless, symmetrical drooping of the eyelids and progressive limitation of eye movements over years

  • Double vision is often absent because both eyes fail together - many first present to opticians or eyelid surgeons

  • Kearns-Sayre syndrome adds onset before 20, retinal pigmentary changes and cardiac conduction disease

  • Cardiac conduction block in KSS can cause sudden death - regular ECGs and a low threshold for pacemakers are essential

  • Caused by mtDNA deletions or nuclear maintenance gene defects; genetics usually replaces biopsy

  • Ptosis surgery and prisms are effective, timed carefully by surgeons experienced in mitochondrial disease

Understanding it

About CPEO and Kearns-Sayre, and what to do next.

CPEO is easily mistaken for tiredness, ageing lids or myasthenia: over years the eyelids descend and gaze stiffens in every direction, usually without diplopia because the limitation is symmetric. The differential from myasthenia (which fluctuates) and other myopathies is made with a mix of clinical pattern, antibody testing and genetics - mitochondrial DNA deletions in muscle or blood, or nuclear genes like POLG and TWNK that disrupt mtDNA maintenance and may bring family history and extra features.

The reason the spectrum matters is Kearns-Sayre syndrome: when the process starts before 20 and involves the retina, the same deletion disease reaches the heart's conduction system, where complete heart block can be the first and final symptom. Guidelines therefore mandate regular ECG surveillance and early pacemaker or defibrillator decisions - the single most outcome-changing intervention in this territory. Beyond the heart: swallow assessment, hearing and endocrine checks (diabetes, parathyroid), and practical ophthalmic care, since well-timed ptosis surgery and prism glasses restore real function. Mitochondrial specialist services coordinate the whole picture and should be involved once the diagnosis is suspected.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them.

Frequently asked

Common questions about CPEO and Kearns-Sayre.

Quick, plain-English answers to what people ask us most.

  • What is CPEO and Kearns-Sayre syndrome?

    Chronic progressive external ophthalmoplegia (CPEO) is a slowly progressive condition causing drooping eyelids and limited eye movement, and sits on a spectrum with Kearns-Sayre syndrome, a more extensive mitochondrial disorder that additionally affects the heart, hearing, and other systems.

  • What causes CPEO and Kearns-Sayre syndrome?

    Both conditions are caused by mitochondrial DNA abnormalities that impair energy production in cells, particularly affecting the muscles controlling eye movement and eyelid position, and in Kearns-Sayre, other organs as well.

  • What are the symptoms of CPEO?

    The main features are slowly progressive drooping eyelids (ptosis) and restricted eye movement in multiple directions, often noticed gradually over months to years rather than suddenly.

  • What additional symptoms occur in Kearns-Sayre syndrome?

    Beyond the eye features of CPEO, Kearns-Sayre syndrome can include heart rhythm problems (conduction block), hearing loss, and other systemic features, which is why cardiac monitoring is a key part of managing this specific diagnosis.

  • Is CPEO or Kearns-Sayre syndrome dangerous?

    CPEO alone mainly affects the eyes and is not typically life-threatening, but Kearns-Sayre syndrome carries a genuine risk from cardiac conduction problems, which can be serious if unmonitored - this is why distinguishing between the two matters clinically.

  • Is CPEO or Kearns-Sayre syndrome hereditary?

    These conditions arise from mitochondrial DNA changes, which have a different inheritance pattern to typical genetic conditions and are usually not straightforwardly passed on in a predictable Mendelian way. Genetic counselling can help clarify individual risk to family members.

  • Can CPEO or Kearns-Sayre syndrome be cured?

    There's currently no cure for the underlying mitochondrial defect, but symptoms can be managed - for example, surgery for significant ptosis, and pacemaker implantation for cardiac conduction problems in Kearns-Sayre syndrome.

  • How is CPEO/Kearns-Sayre syndrome monitored and treated?

    Management includes regular ophthalmology review for the eye features, and, importantly, cardiology follow-up with ECG monitoring for anyone with confirmed or suspected Kearns-Sayre syndrome, given the cardiac conduction risk.

  • How does the condition progress over time?

    CPEO tends to progress slowly over years, with gradually worsening ptosis and eye movement restriction. Kearns-Sayre syndrome can involve a broader, sometimes more significant, progression across multiple organ systems, making regular multidisciplinary follow-up important.

  • When should I see a specialist about possible CPEO or Kearns-Sayre syndrome?

    See a neurologist or ophthalmologist if you notice gradually worsening eyelid drooping or restricted eye movement, especially alongside any heart or hearing symptoms. A private neurology consultation is often available within about two weeks.